Hemoporfin

DB16183InvestigationalSmall molecule

Hemoporfin is a porphyrin derivative combined with vitamin B12 for the treatment of asthenia. Hemoporfin is under investigation in clinical trial NCT03125057 (A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain).

Chemical structure of Hemoporfin
Formula / weight
C34H38N4O6 · 598.7 g/mol (avg)
Also known as
Haematoporphyrin · Hematoporphyrin · Hematoporphyrin ix · Photodyn
Code names
NSC-267084 · NSC-59265

Resolves to

Compound
UNIIHBT6M5H379CAS14459-29-1ChEMBLCHEMBL403729ChEBI36162
Clinical / RWD
RxNorm5164
Structure
InChIKeyUJKPHYRXOLRVJJ-AMPAVEGJSA-NSMILESCC(O)C1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C)=C5C(C)O)C(C)=C4CCC(O)=O)C(CCC(O)=O)=C3C)=C1C
Targets
P30536TSPO
Transporters
Q9Y6L6SLCO1B1Q9UNQ0ABCG2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
4Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Hemoporfin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In